1. P01.034 Prospective evaluation of alternative therapies in glioma patients in France. (19th September 2018) Authors: Le Rhun, E; Lebrun Frenay, C; Devos, P; Darlix, A; Lorgis, V; Ahle, G; Boone, M; Taillandier, L; Curtit, E; Gras, L; Bourg, V; Ramirez, C; Reyns, N; Weller, M; Simon, N Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P14.122 Integrin α5 is a poor prognostic factor in patients with glioblastoma treated by the Stupp protocol. (6th September 2019) Authors: Etienne-Selloum, N; Prades, J; Bello Roufai, D; El Azumi, F; Boone, M; Sevestre, H; Trudel, S; Coutte, A; Desenclos, C; Constans, J; Chauffert, B; Dontenwill, M Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P14.76 Characteristics of anaplastic oligodendrogliomas short-term survivors: a POLA network study. (6th September 2019) Authors: Garnier, L; Dehais, C; Curtit, E; Tabouret, E; Ramirez, C; Vauleon, E; Bourg, V; Boone, M; Figarella-Branger, D; Ducray, F Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P14.92 Study of Glutaminergic and Glutamatergic Metabolism in 1H-MRS Monovoxel in the Most Aggressive Part of 62 Glioblastoma Before and After 18 months Treatment. (6th September 2019) Authors: Heintz, A; Chombar, J; Boussida, S; Saidak, Z; Lefranc, M; Deleval, N; Coutte, A; Chauffert, B; Boone, M; Constans, J Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗